Decreased nicotinic receptors and cognitive deficit in rats intracerebroventricularly injected with beta-amyloid peptide(1-42) and fed a high-cholesterol diet

Journal of Neuroscience Research

Volumn 86, Issue 1, 2008, Pages 183-193

  Liu, Ru Yu ^a   Gu, Ran ^a   Qi, Xiao Lan ^a   Zhang, Ting ^a   Zhao, Yan ^a   He, Yan ^a   Pei, Jin Jing ^b   Guan, Zhi Zhong ^a,b  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

amyloid peptide; Cholesterol; Learning and memory; Nicotinic receptor; Rats

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; COGNITIVE DEFECT; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LEARNING; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHOLESTEROL; COGNITION DISORDERS; DIETARY FATS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INJECTIONS, INTRAVENTRICULAR; MAZE LEARNING; PEPTIDE FRAGMENTS; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; RNA, MESSENGER; SILVER STAINING;

EID: 38049040002     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21463     Document Type: Article

References (67)

1. Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovacs G.G, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H. 2006. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 65:740-757.
2. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. 1974. Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475.
3. Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellstrom-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. 2002. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Mol Cell Neurosci 20:354-365.
4. Bjorkhem I, Meaney S. 2004. Brain Cholesterol: Long Secret Life Behind a Barrier. Arterioscler Thromb Vasc Biol 5:5.
5. Bogdanovic N, Zilmer M, Zilmer K, Rehema A, Karelson E. 2001. The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex. Dement Geriatr Cogn Disord 12:364-370.
6. Chambers CB, Sigurdsson EM, Hejna MJ, Lorens SA, Lee JM, Muma NA. 2000. Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression. Exp Neurol 162:158-170.
7. Cho JY, Kim HS, Kim DH, Yan JJ, Suh HW, Song DK. 2005. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog Neuropsychopharmacol Biol Psychiatry 29:901-907.
8. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL. 2003. Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry 42:12749-12760.
9. Crisby M, Rahman SM, Sylven C, Winblad B, Schultzberg M. 2004. Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice. Implications for Alzheimer's disease and stroke. Neurosci Lett 369:87-92.
10. Dickson DW. 1997. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging 18:S21-S26.
11. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. 2001. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 21:4125-4133.
12. Flood JF, Morley JE, Roberts E. 1991. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. Proc Natl Acad Sci U S A 88:3363-3366.
13. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ. 1992. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
14. Funato H, Yoshimura M, Yamazaki T, Saido TC, Ito Y, Yokofujita J, Okeda R, Ihara Y. 1998. Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain. Am J Pathol 152:983-992.
15. Gonzalo-Ruiz A, Perez JL, Sanz JM, Geula C, Arevalo J. 2006. Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat. Exp Neurol 197:41-55.
16. Guan ZZ, Zhang X, Ravid R, Nordberg A. 2000. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243.
17. Guan ZZ, Nordberg A, Mousavi M, Rinne JO, Hellstrom-Lindahl E. 2002. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Res 956:358-366.
18. Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X. 2001a. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. J Neural Transm 108:1417-1433.
19. Guan ZZ, Zhang X, Mousavi M, Tian JY, Unger C, Nordberg A. 2001b. Reduced expression of neuronal nicotinic acetylcholine receptors during the early stages of damage by oxidative stress in PC12 cells. J Neurosci Res 66:551-558.
20. Guan ZZ, Yu WF, Shan KR, Nordman T, Olsson J, Nordberg A. 2003. Loss of nicotinic receptors induced by beta-amyloid peptides in PC12 cells: possible mechanism involving lipid peroxidation. J Neurosci Res 71:397-406.
21. Haass C. 1996. The molecular significance of amyloid beta-peptide for Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 246:118-123.
22. Hellstrom-Lindahl E, Court J, Keverne J, Svedberg M, Lee M, Marutle A, Thomas A, Perry E, Bednar I, Nordberg A. 2004. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 19:2703-2710.
23. Hellstron-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. 1999. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Res Mol Brain Res 66:94-103.
24. Hoyle E, Genu RF, Fermandes C, Stolerman IP. 2006. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology 189:211-223.
25. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. 1995. Interactions of apolipoprotem E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45:1092-1096.
26. Jhoo JH, Kim HC, Nabeshima T, Yamada K, Shin EJ, Jhoo WK, Kim W, Kang KS, Jo SA, Woo JI. 2004. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 155:185-196.
27. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. 2000. Statins and the risk of dementia. Lancet 356:1627-1631.
28. Kaskie B, Storandt M. 1995. Visuospatial deficit in dementia of the Alzheimer type. Arch Neurol 52:422-425.
29. Kim HJ, Chae SC, Lee DK, Chromy B, Lee SC, Park YC, Klein WL, Krafft GA, Hong ST. 2003. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J 17:118-120.
30. Kimura N, Takahashi M, Tashiro T, Terao K. 2006. Amyloid beta upregulates brain-derived neurotrophic factor production from astrocytes: Rescue from amyloid beta-related neuritic degeneration. J Neurosci Res 84:782-789.
31. Kurt MA, Davies DC, Kidd M. 1999. beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. Exp Neurol 158:221-228.
32. Levin-Allerhand JA, Lominska CE, Smith JD. 2002. Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J Nutr Health Aging 6:315-319.
33. Li Y, Qin HQ, Chen QS, Wang JJ. 2005. Neurochemical and behavioral effects of the intrahippocampal co-injection of beta-amyloid protein1-40 and ibotenic acid in rats. Life Sci 76:1189-1197.
34. Liu Q, Kawai H, Berg DK. 2001. beta-Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 98:4734-4739.
35. Lovasic L, Bauschke H, Janus C. 2005. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Genes Brain Behav 4:197-208.
36. Maier M, Seabrook TJ, Lazo ND, Jiang L, Das P, Janus C, Lemere CA. 2006. Short amyloid-beta (Aβ) immunogens reduce cerebral Aβ load and learning deficits in an Alzheimer's disease mouse model in the absence of an Aβ-specific cellular immune response. J Neurosci 26:4717-4728.
37. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK. 1999. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem 73:1635-1640.
38. Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631-639.
39. Mazzola C, Micale V, Drago F. 2003. Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol 477:219-225.
40. Moghadasian MH, Frohlich JJ, Scudamore CH. 2002. Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J Clin Pathol 55:859-861.
41. Mori T, Paris D, Town T, Rojiani AM, Sparks DL, Delledonne A, Crawford F, Abdullah LI, Humphrey JA, Dickson DW, Mullan MJ. 2001. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice. J Neuropathol Exp Neurol 60:778-785.
42. Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
43. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY. 2003. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 971:197-209.
44. Nordberg A. 2001. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49:200-210.
45. Nordberg A. 2003. Toward an early diagnosis and treatment of Alzheimer's disease. Int. Psychogeriatrics 15:223-237.
46. Paterson D, Nordberg A. 2000. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111.
47. Pepeu G, Giovannelli L, Casamenti F, Scali C, Bartolini L. 1996. Amyloid beta-peptides injection into the cholinergic nuclei: morphological, neurochemical and behavioral effects. Prog Brain Res 109:273-282.
48. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:321-331.
49. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
50. Simons M, Keller P, Dichgans J, Schulz JB. 2001. Cholesterol and Alzheimer's disease: is there a link? Neurology 57:1089-1093.
51. Steinhoff T, Moritz E, Wollmer MA, Mohajeri MH, Kins S, Nitsch RM. 2001. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Neurobiol Dis 8:647-654.
52. Stepanichev MY, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV. 2003. Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats. Brain Res Bull 61:197-205.
53. Terai K, Iwai A, Kawabata S, Sasamata M, Miyata K, Yamaguchi T. 2001. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease. Brain Res 900:48-56.
54. Walsh DT, Bresciani L, Saunders D, Manca MF, Jen A, Gentleman SM, Jen LS. 2005. Amyloid beta peptide causes chronic glial cell activation and neuro-degeneration after intravitreal injection. Neuropathol Appl Neurobiol 31:491-502.
55. Wevers A, Monteggia L, Nowacki S, Bloch W, Schutz U, Lindstrom J, Pereira EF, Eisenberg H, Giacobini E, de Vos RA, Steur EN, Maelicke A, Albuquerque EX, Schroder H. 1999. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur J Neurosci 11:2551-2565.
56. Wevers A, Burghaus L, Moser N, Witter B, Steinlein OK, Schutz U, Achnitz B, Krempel U, Nowacki S, Pilz K, Stoodt J, Lindstrom J, De Vos RA, Jansen Steur EN, Schroder H. 2000. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Behav Brain Res 113:207-215.
57. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. 2000. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439-1443.
58. Wood WG, Schroeder F, Igbavboa U, Avdulov NA, Chochina SV. 2002. Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol Aging 23:685-694.
59. Xiu J, Nordberg A, Zhang JT, Guan ZZ. 2005. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochem Int 47:281-290.
60. Xiu J, Nordberg A, Qi X, Guan ZZ. 2006. Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes. Neurochem Int 49:459-465.
61. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T. 1999a. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)- induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11:83-90.
62. Yamada K, Tanaka T, Zou LB, Senzaki K, Yano K, Osada T, Ana O, Ren X, Kameyama T, Nabeshima T. 1999b. Long-term deprivation of oestrogens by ovariectomy potentiates beta-amyloid-induced working memory deficits in rats. Br J Pharmacol 128:419-427.
63. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. 2006. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Therapeut 317:1079-1087.
64. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, Spratt C, Finlayson K, Sharkey J. 2007. Impaired attention is central to the cognitive deficits observed in alpha7 deficient mice. Eur Neuropsychopharmacol 17:145-155.
65. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, Kelly JS, Sharkey J. 2004. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology. 29:891-900.
66. Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. 2005. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Exp Neurol 192:215-225.
67. Zatta P, Zambenedetti P, Stella MP, Licastro F. 2002. Astrocytosis, microgliosis, metallothionein-I-II and amyloid expression in high cholesterol-fed rabbits. J Alzheimer Dis 4:1-9.